Exogenous Insulin Antibody Syndrome in Patients with Type 2 Diabetes

BACKGROUND: Exogenous insulin antibody syndrome (EIAS) is an immunological disorder caused by circulating insulin antibodies (IAs), featuring hypersensitivity to exogenous insulin and insulin resistance. With the wide use of recombinant human insulin and insulin analogs, there has been a significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Chen-Yu, Ye, Xiao-Mei, Lu, Jia-Ping, Jin, Hai-Ying, Xu, Wei-Wei, Wang, Ping, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312206/
https://www.ncbi.nlm.nih.gov/pubmed/37398942
http://dx.doi.org/10.2147/DMSO.S410349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312206/
https://www.ncbi.nlm.nih.gov/pubmed/37398942
http://dx.doi.org/10.2147/DMSO.S410349

Ejemplares similares